Our platforms combine injection-molded microfluidics, purpose-built optics, robotic liquid handling, and AI computer vision into complete, automated systems.
A chip alone does not change how a lab works. Every Omni platform ships with the optics, automation, and analysis pipeline needed to run it unattended and read it out in minutes.
Ex-vivo immuno-oncology on a chip. A compartmentalized four-zone device recreates the 3D tumor microenvironment, and a micropillar barrier makes immune cell recruitment, infiltration, and cytolytic kill directly quantifiable — five or more readouts from a single run, with cells recovered afterwards for transcriptomics.
The same capability stack — chip, optics, robotics, AI — applied to new disease areas and assay classes. We are actively scoping the next platform with partners.
Talk to us about yours →Injection-molded and compartmentalized, mass-produced with semiconductor fabrication techniques.
TRL 5Purpose-built imaging for live, longitudinal capture of cells inside the chip.
TRL 3Automated seeding, dosing, and media exchange for hands-off, reproducible runs.
TRL 4Segmentation, classification, and tracking that cut read-out time by 5–20×.
TRL 4OncoMiMIC is available today. If your assay needs a platform that does not exist yet, that is a conversation we would like to have.
Get in touch →